Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
SIB Swiss Institute of Bioinformatics | RCV000993681 | SCV001146835 | uncertain significance | Neurodevelopmental disorder with or without variable brain abnormalities; NEDBA | 2019-10-02 | criteria provided, single submitter | curation | This variant is interpreted as a variant of uncertain significance for Neurodevelopmental disorder with or without variable brain abnormalities, autosomal dominant. The following ACMG Tag(s) were applied: PM2, PP3. |
Institute of Human Genetics, |
RCV000993681 | SCV001335370 | likely pathogenic | Neurodevelopmental disorder with or without variable brain abnormalities; NEDBA | 2019-02-07 | criteria provided, single submitter | clinical testing | This variant was identified as de novo (maternity and paternity confirmed). |
Genome |
RCV003313162 | SCV004012837 | not provided | not provided | no assertion provided | phenotyping only | Variant interpreted as Uncertain significance and reported on 05-05-2017 by Lab GeneDx. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator Dr. Philip Payne from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/. |